Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

Information on the molecular distribution and ageing trend of brain iron in post‐mortem material from normal subjects is scarce. Because it is known that neuromelanin and ferritin form stable complexes with iron(III), in this study we measured the concentration of iron, ferritin and neuromelanin in substantia nigra from normal subjects, aged between 1 and 90 years, dissected post mortem. Iron levels in substantia nigra were 20 ng/mg in the first year of life, had increased to 200 ng/mg by the fourth decade and remained stable until 90 years of age. The H‐ferritin concentration was also very low (29 ng/mg) during the first year of life but increased rapidly to values of ≈ 200 ng/mg at 20 years of age, which then remained constant until the eighth decade of life. L‐Ferritin also showed an increasing trend during life although the concentrations were ≈ 50% less than that of H‐ferritin at each age point. Neuromelanin was not detectable during the first year, increased to ≈ 1000 ng/mg in the second decade and then increased continuously to 3500 ng/mg in the 80th year. A Mössbauer study revealed that the high‐spin trivalent iron is probably arranged in a ferritin‐like iron−oxyhydroxide cluster form in the substantia nigra. Based on this data and on the low H‐ and L‐ferritin content in neurones it is concluded that neuromelanin is the major iron storage in substantia nigra neurones in normal individuals.

[1]  B. Engelhardt Development of the blood-brain barrier , 2003, Cell and Tissue Research.

[2]  R. Crichton Inorganic biochemistry of iron metabolism , 2001 .

[3]  G. Bartzokis,et al.  MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. , 2000, Cellular and molecular biology.

[4]  S. Ito,et al.  Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides , 2000, Journal of neurochemistry.

[5]  B. Bergamasco,et al.  Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. , 2000, Biochimica et biophysica acta.

[6]  Y. Agid,et al.  Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.

[7]  C. C. Johnson,et al.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. , 1999, Neurotoxicology.

[8]  P D Griffiths,et al.  Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.

[9]  L. Pannell,et al.  Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines* , 1999, The Journal of Biological Chemistry.

[10]  L. Zecca,et al.  X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues. , 1998, Biophysical journal.

[11]  A. Lees,et al.  Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species , 1998, Journal of neurochemistry.

[12]  S. Ito,et al.  Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? , 1998, Neuroscience Letters.

[13]  U. Muthane,et al.  Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India , 1998, Annals of neurology.

[14]  C. Beaumont,et al.  Transient overexpression of human H- and L-ferritin chains in COS cells. , 1998, The Biochemical journal.

[15]  F Beermann,et al.  New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. , 1998, Brain research. Molecular brain research.

[16]  K. Marder,et al.  Altered systemic iron metabolism in Parkinson's disease , 1997, Neurology.

[17]  A. Barzilai,et al.  Dopamine–melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease , 1997, Neurochemistry International.

[18]  A H Stokes,et al.  Tyrosinase mRNA is expressed in human substantia nigra. , 1997, Brain research. Molecular brain research.

[19]  T. Shima,et al.  Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. , 1997, Free radical biology & medicine.

[20]  B. Xia,et al.  Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease. , 1996, Chemical research in toxicology.

[21]  H. M. Swartz,et al.  Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.

[22]  S. LeVine,et al.  The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. , 1996, Brain research. Developmental brain research.

[23]  John Smythies,et al.  On the function of neuromelanin , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[24]  M. Barcikowska,et al.  Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study , 1996, Movement disorders : official journal of the Movement Disorder Society.

[25]  J. Connor,et al.  Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.

[26]  J. Connor,et al.  A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.

[27]  P. Riederer,et al.  Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra , 1995, Journal of neurochemistry.

[28]  T. Sarna,et al.  The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. , 1995, Biochimica et biophysica acta.

[29]  G. Dryhurst,et al.  Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. , 1994, Journal of medicinal chemistry.

[30]  S. Benkovic,et al.  Isoforms of ferritin have a specific cellular distribution in the brain , 1994, Journal of neuroscience research.

[31]  D. Radice,et al.  Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain , 1994, Journal of neurochemistry.

[32]  H. M. Swartz,et al.  Total and paramagnetic metals in human substantia nigra and its neuromelanin , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[33]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[34]  Y. Agid,et al.  Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? , 1992, Journal of neurochemistry.

[35]  K. Jellinger,et al.  Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.

[36]  D. Donaldson,et al.  Inorganic Biochemistry of Iron Metabolism , 1992 .

[37]  W. Gibb,et al.  Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease , 1992, Brain Research.

[38]  E. Parati,et al.  The chemical characterization of melanin contained in substantia nigra of human brain. , 1992, Biochimica et biophysica acta.

[39]  T. Sarna,et al.  Modulation by neuromelanin of the availability and reactivity of metal ions , 1992, Annals of neurology.

[40]  P. Riederer,et al.  Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease , 1991, Journal of neurochemistry.

[41]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[42]  H. Tohgi,et al.  [Aging and Parkinson's disease]. , 1991, No to shinkei = Brain and nerve.

[43]  H J Gundersen,et al.  The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[44]  E. Bill,et al.  Iron-containing proteins and related analogs — complementary Mössbauer, EPR and magnetic susceptibility studies , 1991 .

[45]  J. Connor,et al.  Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.

[46]  E. Taylor,et al.  Developmental changes in transferrin and iron uptake by the brain in the rat. , 1990, Brain research. Developmental brain research.

[47]  C. Marsden,et al.  Decreased Ferritin Levels in Brain in Parkinson's Disease , 1990, Journal of neurochemistry.

[48]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[49]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[50]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[51]  N. Lindquist,et al.  Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin , 1988, Neuroscience Letters.

[52]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[53]  G. Ruggeri,et al.  Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. , 1986, Biochimica et biophysica acta.

[54]  S. Snyder,et al.  Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. , 1986, Science.

[55]  M. Weir,et al.  Mössbauer spectroscopic studies of human haemosiderin and ferritin. , 1984, Biochimica et biophysica acta.

[56]  P. Mcgeer,et al.  Aging and extrapyramidal function. , 1977, Archives of neurology.

[57]  P. Yates,et al.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. , 1974, Brain : a journal of neurology.

[58]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[59]  J. Dobbing The development of the blood-brain barrier. , 1968, Progress in brain research.

[60]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[61]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.